| Capsaicin |
NCT03317613 |
Recruiting |
Phase 2 |
Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain |
Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT03317613 |
| Capsaicin |
NCT04125563 |
Recruiting |
Phase 2 |
Influence on Cough and Airway Symptoms by Oral Capsaicin |
Cough |
https://ClinicalTrials.gov/show/NCT04125563 |
| Capsaicin |
NCT04283292 |
Not yet recruiting |
Phase 4 |
Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome |
Cannabinoid Hyperemesis Syndrome |
https://ClinicalTrials.gov/show/NCT04283292 |
| Capsaicin |
NCT02441660 |
Recruiting |
Not Applicable |
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain |
Spinal Cord Injuries|Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT02441660 |
| Capsaicin |
NCT03899246 |
Active, not recruiting |
Phase 1 |
Sickle Cell Pain: Intervention With Capsaicin Exposure |
Neuropathic Pain|Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT03899246 |
| Capsaicin |
NCT02037464 |
Unknown status |
Phase 2 |
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer |
Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02037464 |
| Capsaicin |
NCT02603783 |
Completed |
Not Applicable |
Esophageal capsaĂŻcin Infusion and Mucosal Integrity |
TRPV1 Protein, Human|Capsaicin|Electric Impedance|Esophagus|Intracellular Space|Pain Measurement|Microscopy, Electron |
https://ClinicalTrials.gov/show/NCT02603783 |
| Capsaicin |
NCT02570841 |
Completed |
Phase 4 |
Pain Thresholds Under High-dose Topical Capsaicin |
Pain |
https://ClinicalTrials.gov/show/NCT02570841 |
| Capsaicin |
NCT02346903 |
Unknown status |
Not Applicable |
Chest Pain Perception and Capsaicin Sensitivity |
Chest Pain |
https://ClinicalTrials.gov/show/NCT02346903 |
| Capsaicin |
NCT02346916 |
Unknown status |
Not Applicable |
Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia |
Chest Pain |
https://ClinicalTrials.gov/show/NCT02346916 |
| Capsaicin |
NCT02493257 |
Completed |
Phase 2 |
Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis |
Nonallergic Irritant Rhinitis |
https://ClinicalTrials.gov/show/NCT02493257 |
| Capsaicin |
NCT00655811 |
Completed |
Phase 4 |
Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects |
Healthy |
https://ClinicalTrials.gov/show/NCT00655811 |
| Capsaicin |
NCT01260454 |
Completed |
Phase 2 |
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain |
Pulmonary Hypertension|Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT01260454 |
| Capsaicin |
NCT02551029 |
Recruiting |
Not Applicable |
fMRI and Visceral Perception Upon Capsaicin Infusion |
Irritable Bowel Syndrome|Colonic Diseases, Functional|Dyspepsia|Gastrointestinal Diseases|Abdominal Pain|Visceral Pain |
https://ClinicalTrials.gov/show/NCT02551029 |
| Capsaicin |
NCT01704339 |
Unknown status |
Phase 4 |
Qutenza for Critical Ischaemia in End Stage Renal Failure |
End Stage Renal Failure|Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT01704339 |
| Capsaicin |
NCT01533428 |
Completed |
Phase 3 |
A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) |
Diabetic Peripheral Neuropathy|Pain |
https://ClinicalTrials.gov/show/NCT01533428 |
| Capsaicin |
NCT03576508 |
Completed |
Phase 1 |
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis |
Knee Osteoarthritis |
https://ClinicalTrials.gov/show/NCT03576508 |
| Capsaicin |
NCT03146689 |
Completed |
Not Applicable |
Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis? |
Osteoarthritis, Knee |
https://ClinicalTrials.gov/show/NCT03146689 |
| Capsaicin |
NCT04238208 |
Completed |
Phase 4 |
The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy |
Diabetic Nerve Problems|Diabetic Neuropathy|Diabetic Complications Neurological |
https://ClinicalTrials.gov/show/NCT04238208 |
| Capsaicin |
NCT01223820 |
Completed |
Phase 4 |
Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin. |
Idiopathic Rhinitis Patients|Healthy Controls |
https://ClinicalTrials.gov/show/NCT01223820 |
| Capsaicin |
NCT01667523 |
Completed |
Not Applicable |
The Effect of Capsaicin and Cinnamaldehyde on Intestinal Permeability |
Healthy |
https://ClinicalTrials.gov/show/NCT01667523 |
| Capsaicin |
NCT01748422 |
Unknown status |
N/A |
Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae |
Neuropathic Pain|Arteriovenous Fistulae |
https://ClinicalTrials.gov/show/NCT01748422 |
| Capsaicin |
NCT01748435 |
Unknown status |
N/A |
Pre-emptive Analgesia With Qutenza in Lower Limb Amputation |
Neuropathic Pain|Lower Limb Amputation |
https://ClinicalTrials.gov/show/NCT01748435 |
| Capsaicin |
NCT02065128 |
Withdrawn |
N/A |
The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome |
Cough|Larynx |
https://ClinicalTrials.gov/show/NCT02065128 |
| Capsaicin |
NCT02823912 |
Unknown status |
Phase 2|Phase 3 |
Capsaicin Effect on Cytokines Profile in Dyslipidemia |
Dyslipidemia|Overweight or Obesity |
https://ClinicalTrials.gov/show/NCT02823912 |
| Capsaicin |
NCT03859583 |
Recruiting |
Not Applicable |
Capsaicin Energy Expenditure and Glucose Metabolism |
Obesity|Insulin Resistance |
https://ClinicalTrials.gov/show/NCT03859583 |
| Capsaicin |
NCT01596491 |
Completed |
N/A |
Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain |
Peripheral Nerve Injury|Postherpetic Neuralgia |
https://ClinicalTrials.gov/show/NCT01596491 |
| Capsaicin |
NCT01200745 |
Unknown status |
Not Applicable |
Efficacy of Topical Capsaicin on Chronic Neck Pain |
Chronic Neck Pain |
https://ClinicalTrials.gov/show/NCT01200745 |
| Capsaicin |
NCT03113448 |
Completed |
Phase 3 |
0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy |
Peripheral Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT03113448 |
| Capsaicin |
NCT03223350 |
Completed |
Phase 2 |
Topical Capsaicin for Cyclical Vomiting |
Cyclical Vomiting |
https://ClinicalTrials.gov/show/NCT03223350 |
| Capsaicin |
NCT01737294 |
Completed |
N/A |
Observation of the Use of QUTENZA™ in Standard Clinical Practice |
Peripheral Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT01737294 |
| Capsaicin |
NCT03587220 |
Active, not recruiting |
Not Applicable |
A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin |
Capsaicin|Ultaviolet B Light Burn|Neuropathic Pain|Lidocaine |
https://ClinicalTrials.gov/show/NCT03587220 |
| Capsaicin |
NCT01231750 |
Terminated |
Phase 3 |
Efficacy of Topical Capsaicin Cream for Stable Angina |
Stable Angina |
https://ClinicalTrials.gov/show/NCT01231750 |
| Capsaicin |
NCT01963910 |
Completed |
Not Applicable |
Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream |
Pain |
https://ClinicalTrials.gov/show/NCT01963910 |
| Capsaicin |
NCT03330639 |
Unknown status |
Not Applicable |
Capsaicin in Treatment of Rhinogenic Headache |
Headache Disorders |
https://ClinicalTrials.gov/show/NCT03330639 |
| Capsaicin |
NCT01125215 |
Unknown status |
Phase 2|Phase 3 |
Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy |
Painful Diabetic Neuropathy |
https://ClinicalTrials.gov/show/NCT01125215 |
| Capsaicin |
NCT00583180 |
Completed |
N/A |
Sensory Function After Wound Instillation of Capsaicin |
Primary Hyperalgesia |
https://ClinicalTrials.gov/show/NCT00583180 |
| Capsaicin |
NCT01807832 |
Unknown status |
Not Applicable |
The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough. |
Chronic Cough |
https://ClinicalTrials.gov/show/NCT01807832 |
| Capsaicin |
NCT02171182 |
Completed |
N/A |
A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain |
Post-operative Peripheral Neuropathic Pain |
https://ClinicalTrials.gov/show/NCT02171182 |
| Capsaicin |
NCT03638063 |
Recruiting |
N/A |
ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis |
Chronic Cough|Bronchiectasis |
https://ClinicalTrials.gov/show/NCT03638063 |
| Capsaicin |
NCT02854670 |
Unknown status |
Phase 2|Phase 3 |
A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia |
Vestibulodynia |
https://ClinicalTrials.gov/show/NCT02854670 |
| Capsaicin |
NCT01862523 |
Completed |
Phase 4 |
Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls |
Rhinitis |
https://ClinicalTrials.gov/show/NCT01862523 |
| Capsaicin |
NCT00795106 |
Withdrawn |
Phase 2 |
Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain |
Myofascial Pain Syndrome |
https://ClinicalTrials.gov/show/NCT00795106 |
| Capsaicin |
NCT03794388 |
Recruiting |
Phase 3 |
Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery |
Breast Cancer Patient |
https://ClinicalTrials.gov/show/NCT03794388 |
| Capsaicin |
NCT02822625 |
Completed |
Phase 3 |
Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch |
Pain |
https://ClinicalTrials.gov/show/NCT02822625 |
| Capsaicin |
NCT01883102 |
Completed |
Phase 1 |
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream |
Pain |
https://ClinicalTrials.gov/show/NCT01883102 |
| Capsaicin |
NCT03153813 |
Terminated |
Phase 3 |
Capsaicin Patches In Knee Osteoarthritis In Obese Patients |
Pain |
https://ClinicalTrials.gov/show/NCT03153813 |
| Capsaicin |
NCT00993070 |
Completed |
Phase 2|Phase 3 |
Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy |
Diabetic Polyneuropathy |
https://ClinicalTrials.gov/show/NCT00993070 |
| Capsaicin |
NCT01621685 |
Completed |
Phase 1 |
Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older Men |
COPD |
https://ClinicalTrials.gov/show/NCT01621685 |
| Capsaicin |
NCT01974037 |
Completed |
Phase 4 |
Capsaicin on Salty Gustatory Cortices |
Volunteers |
https://ClinicalTrials.gov/show/NCT01974037 |
